Eric Dozier
VP, Oncology North America, Lilly OncologyAuthored Items
April 9, 2020 | May 2020 Vol 11, No 5
The healthcare supply channel is dependent on drug manufacturers and their innovation and production. Representing 3 of the major biopharmaceutical companies, Dr Gerberding, Mr Morrissey, and Mr Dozier discussed the drug manufacturers’ response to the COVID-19 pandemic, announcing a recent collaboration in the fight against the novel coronavirus.
Last modified: March 10, 2021
